 |
|
PNEUMONIA DUE TO BACILLUS FRIEDLÄNDERIA REPORT ON FORTY-ONE PATIENTS, WITH CONSIDERATION OF SPECIFIC SERUM THERAPY
JESSE G. M. BULLOWA, M.D.;
JOSEPH CHESS, M.D.;
NATHAN B. FRIEDMAN, M.D.
Arch Intern Med. 1937;60(5):735-752.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The existence of pulmonary disease attributable to Bacillus Friedländeri has been recognized for a number of years. Most of the previous reports have been based on isolated cases or small groups of cases, with two or three outbreaks approaching epidemic proportions. Examination of these reports reveals that they have been concerned with various features of the organism and the disease.
There have been extensive bacteriologic, cultural and immunologic studies of Friedländeri, with more recent work on their subdivision into several morphologically identical but serologically distinct groups. These have been further concerned with the etiologic significance of the presence of B. Friedländeri in diseased pulmonary tissue and its relative incidence in the pneumonias, in extrapulmonary diseases and in the carrier state.
Clinical study has distinguished the chronic form of the disease, which simulates pulmonary tuberculosis, from the acute fulminating form, with a uniformly high mortality rate, like that of pneumococcic lobar
. . . [Full Text PDF of this Article]
Author Affiliations
Clinical Professor of Medicine, New York University College of Medicine.; Residents, Service for Acute Disease of Respiratory Tract, the Harlem Hospital NEW YORK
From the Littauer Pneumonia Research Fund, New York University; the Medical Service, the Harlem Hospital, and the Bureau of Laboratories, the Department of Health.
Footnotes
This study received support in part from the Metropolitan Life Insurance Company.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
